GO:0005692 U11 snRNP: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0005692 defines the U11 snRNP, a ribonucleoprotein complex containing U11 snRNA, a heptameric Sm ring, and U11-specific proteins.
• The U11 snRNP is a core component of the minor spliceosome, which removes U12-type introns from a subset of pre-mRNAs.
• U11 snRNP interacts with the U12 snRNP to form the 18S U11/U12 di-snRNP, essential for minor spliceosome assembly.
• The U11-65K protein acts as a molecular bridge between U11-59K and U12 snRNA, stabilizing the U11/U12 complex.
• U11 snRNP participates in exon definition and alternative splicing regulation of its own components, such as U11-48K and U11/U12-65K.
• Dysregulation of U11 snRNP components is linked to diseases including cancer and developmental disorders, making it a target for CRISPR modeling.
Description
The U11 snRNP (small nuclear ribonucleoprotein) is a cellular component defined by GO:0005692. It is a ribonucleoprotein complex that contains the small nuclear RNA U11, a heptameric ring of Sm proteins, and several unique proteins that remain associated with U11 snRNA whether free or assembled into spliceosomal complexes. This complex is essential for the minor spliceosome, which processes U12-type introns, a rare but critical class of introns in eukaryotic genomes. Understanding the U11 snRNP is vital for researchers studying RNA splicing, gene regulation, and related diseases. Its unique protein composition and dynamic interactions with the U12 snRNP make it a key target for structural and functional studies. Recent advances in cryo-EM have revealed the architecture of the fully assembled human minor spliceosome, highlighting the central role of U11 snRNP. This article synthesizes authoritative QuickGO data and verified PubMed literature to provide a comprehensive overview of U11 snRNP, its components, mechanisms, and research methodologies.
U11 snRNP At A Glance
| GO ID | GO:0005692 |
|---|---|
| GO term | U11 snRNP |
| Ontology | cellular_component |
| Synonym | 12S U11 snRNP, snRNP U11 |
| Major function | Component of the minor spliceosome; involved in recognition and removal of U12-type introns |
| Composition | U11 snRNA, Sm proteins, and U11-specific proteins such as U11-35K, U11-48K, U11-59K, U11-65K |
| Assembly | Forms a di-snRNP complex with U12 snRNP; interacts with U6atac and other spliceosomal components |
| Related diseases | Implicated in cancer, developmental disorders, and splicing-related diseases |
What Is GO:0005692?
The U11 snRNP is a ribonucleoprotein complex that contains the small nuclear RNA U11, a heptameric ring of Sm proteins, and several proteins unique to the U11 snRNP. Most of these unique proteins remain associated with U11 snRNA both when the U11 snRNP is free and when it is assembled into a series of spliceosomal complexes.
Why Is U11 snRNP Important in Cell Biology?
The U11 snRNP is crucial for the minor spliceosome pathway, which regulates a subset of genes essential for cell cycle, DNA repair, and development. Its dysfunction can lead to widespread splicing defects and has been associated with human diseases, including cancer and developmental abnormalities. Studying U11 snRNP provides insights into RNA processing and offers potential therapeutic targets.
• Essential for minor spliceosome assembly and U12-type intron removal.
• Regulates alternative splicing of its own components, creating feedback loops.
• Mutations in U11 snRNP components are linked to developmental disorders and cancer.
• Serves as a model for studying snRNP biogenesis and RNA-protein interactions.
• Target for CRISPR-based knockout and knock-in studies to dissect splicing mechanisms.
• Involved in exon definition interactions that influence splice site selection.
• Potential biomarker for splicing-related diseases.
• Structural studies reveal unique features compared to major spliceosome.
Core Biology of U11 snRNP
Assembly and Di-snRNP Formation
In simple terms: The U11 snRNP joins with U12 snRNP to form a pair, which is the first step in minor spliceosome assembly.
The U11 snRNP interacts with the U12 snRNP to form a two-snRNP complex, known as the 18S U11/U12 di-snRNP. This interaction is mediated by the U11/U12-65K protein, which acts as a molecular bridge binding both U12 snRNA and U11-59K protein. The di-snRNP is essential for the minor spliceosome to recognize U12-type introns.
Role in Minor Spliceosome Activation
In simple terms: After forming the di-snRNP, the minor spliceosome undergoes activation steps to become catalytically active.
The fully assembled human minor spliceosome engages U12-type introns through a series of structural rearrangements. The U11 snRNP remains associated with the spliceosome during activation, contributing to the recognition of the 5' splice site and branch point. The activated minor spliceosome structure reveals the positioning of U11 snRNP components relative to the catalytic core.
Protein Composition and Unique Factors
In simple terms: The U11 snRNP contains specific proteins that are not found in the major spliceosome, giving it unique functions.
The human 18S U11/U12 snRNP contains a set of novel proteins not found in the U2-dependent spliceosome, including U11-35K, U11-48K, U11-59K, and U11-65K. These proteins are essential for U11 snRNP function and stability. The U11-48K protein is regulated by hnRNPH1/H2 and U1 snRNP, which cooperate to control its pre-mRNA stability.
Regulation of U11 snRNP Components
In simple terms: The levels of U11 snRNP proteins are controlled by feedback mechanisms involving splicing factors.
Evolutionarily conserved exon definition interactions with U11 snRNP mediate alternative splicing regulation of U11-48K and U11/U12-65K genes. This autoregulatory loop ensures proper stoichiometry of U11 snRNP components. Additionally, recycling of the U12-type spliceosome requires p110, a component of the U6atac snRNP, which may indirectly affect U11 snRNP dynamics.
Key Genes Involved in GO:0005692 U11 snRNP
The following genes encode proteins and RNAs that are components or regulators of the U11 snRNP, based on verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| RNU11 | Encodes U11 snRNA | Core RNA component of U11 snRNP |
| SNRPB | Sm protein B | Part of heptameric Sm ring |
| SNRPD1 | Sm protein D1 | Sm ring component |
| SNRPD2 | Sm protein D2 | Sm ring component |
| SNRPD3 | Sm protein D3 | Sm ring component |
| SNRPE | Sm protein E | Sm ring component |
| SNRPF | Sm protein F | Sm ring component |
| SNRPG | Sm protein G | Sm ring component |
| ZCRB1 | U11-35K protein | U11-specific protein |
| RNPC3 | U11-65K protein | Molecular bridge between U11-59K and U12 snRNA |
| SNRNP48 | U11-48K protein | U11-specific protein; regulated by hnRNPH1/H2 |
| SNRNP35 | U11-59K protein | U11-specific protein; interacts with U11-65K |
| U12 | U12 snRNA | Partners with U11 snRNP in di-snRNP |
| U6atac | U6atac snRNA | Component of minor spliceosome; interacts with U11/U12 |
| PRPF8 | Pre-mRNA processing factor 8 | Component of minor spliceosome |
| EFTUD2 | Elongation factor Tu GTP binding domain containing 2 | Component of minor spliceosome |
| HNRNPH1 | Heterogeneous nuclear ribonucleoprotein H1 | Regulates U11-48K pre-mRNA stability |
| HNRNPH2 | Heterogeneous nuclear ribonucleoprotein H2 | Regulates U11-48K pre-mRNA stability |
How Is U11 snRNP Regulated?
The U11 snRNP is regulated at multiple levels. The stability of U11-48K pre-mRNA is controlled by hnRNPH1/H2, U1 snRNP, and U11 snRNP itself, forming a feedback loop. Additionally, exon definition interactions with U11 snRNP mediate alternative splicing of U11-48K and U11/U12-65K genes, ensuring proper component stoichiometry. Recycling of the U12-type spliceosome requires p110, which may influence U11 snRNP availability.
U11 snRNP and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| RNPC3 | Developmental disorder with growth retardation | Knockout mouse or patient-derived iPSCs |
| SNRNP48 | Cancer progression and splicing dysregulation | CRISPR knockout in cancer cell lines |
| ZCRB1 | Potential role in cancer and splicing | Overexpression and knockout models |
| SNRNP35 | Implicated in splicing-related diseases | Point mutation knock-in in cell lines |
| HNRNPH1 | Neurological disorders and cancer | Knockout and overexpression models |
Cancer
Dysregulation of minor spliceosome components, including U11 snRNP proteins, has been observed in various cancers. Mutations in U11 snRNP-specific genes can lead to aberrant splicing of tumor suppressors and oncogenes, contributing to cancer progression.
Developmental Disorders
Mutations in genes encoding U11 snRNP components, such as RNPC3 (U11-65K), have been linked to developmental disorders characterized by growth retardation and intellectual disability. These defects arise from impaired minor spliceosome function during development.
Splicing-Related Diseases
Defects in U11 snRNP can cause widespread splicing abnormalities, leading to diseases such as retinitis pigmentosa and microcephaly. The minor spliceosome's role in processing U12-type introns of genes critical for neuronal development underscores its importance.
From U11 snRNP-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the role of U11-65K in minor spliceosome assembly? | Knockout of RNPC3 in HeLa cells followed by RNA-seq |
| How does U11-48K autoregulation affect splicing? | Point mutation in SNRNP48 3' splice site |
| What are the structural dynamics of U11 snRNP? | Knock-in of tagged U11-59K for cryo-EM |
| Can overexpression of U11-35K rescue splicing defects? | Overexpression of ZCRB1 in patient fibroblasts |
| What is the interactome of U11 snRNP? | Knock-in of APEX2 tag into SNRNP35 |
| How do disease mutations in RNPC3 affect splicing? | Knock-in of patient mutations in iPSCs |
How to Study the U11 snRNP Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Splicing changes and gene expression | Knockout of U11 snRNP components |
| Mass spectrometry | Protein-protein interactions | Identifying U11 snRNP interactome |
| Cryo-EM | 3D structure of spliceosomal complexes | Structural analysis of minor spliceosome |
| CRISPR knockout | Loss-of-function phenotypes | Studying essentiality of U11 snRNP genes |
| CRISPR knock-in | Tagged protein localization and function | Live-cell imaging of U11 snRNP |
| Ribo-seq | Translation efficiency | Assessing impact on protein synthesis |
| CLIP-seq | RNA binding sites of U11 snRNP proteins | Mapping U11 snRNA interactions |
| Immunofluorescence | Subcellular localization | Visualizing U11 snRNP in cells |
RNA Sequencing (RNA-seq)
RNA-seq is used to quantify splicing changes upon U11 snRNP perturbation. It measures intron retention and exon skipping events, particularly for U12-type introns.
Proteomics and Interactomics
Affinity purification coupled with mass spectrometry identifies U11 snRNP-associated proteins. This method has revealed novel components like U11-35K and U11-48K.
Cryo-Electron Microscopy (Cryo-EM)
Cryo-EM determines the high-resolution structure of the minor spliceosome, including U11 snRNP, providing insights into its assembly and catalytic mechanism.
CRISPR Screening
Genome-wide CRISPR knockout screens can identify genes that modulate U11 snRNP function or synthetic lethality with splicing defects.
How CRISPR Can Be Used to Study GO:0005692 U11 snRNP
Knockout
CRISPR knockout of U11 snRNP genes, such as RNPC3 or SNRNP48, can reveal their essentiality and impact on minor splicing. Knockout cell lines are valuable for studying splicing defects and identifying compensatory pathways.
Point Mutation
Introducing patient-specific point mutations into U11 snRNP genes using CRISPR allows functional dissection of disease variants. For example, mutations in RNPC3 can be modeled to study developmental disorders.
Knock-in
Knock-in of epitope tags or fluorescent proteins into endogenous U11 snRNP genes enables live-cell imaging and proteomic studies. Tagged U11-59K or U11-48K can be used to track complex assembly.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression can elevate U11 snRNP component levels to study gain-of-function effects and rescue experiments. Overexpression of U11-35K may rescue splicing defects in disease models.
How EDITGENE Supports U11 snRNP Research
Researchers studying U11 snRNP-related genes often need to determine whether a candidate gene is causally involved in splicing regulation or disease. EDITGENE provides comprehensive CRISPR services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for U11 snRNP research.
Frequently Asked Questions About U11 snRNP
What is U11 snRNP?
U11 snRNP is a ribonucleoprotein complex containing U11 snRNA, Sm proteins, and unique proteins, essential for minor spliceosome function.
What genes are involved in U11 snRNP?
Key genes include RNU11, SNRPB, SNRPD1, ZCRB1, RNPC3, SNRNP48, and SNRNP35, among others.
What is the function of U11 snRNP?
It recognizes U12-type introns and facilitates their removal by the minor spliceosome.
How is U11 snRNP assembled?
It forms a di-snRNP with U12 snRNP, mediated by U11-65K, and then integrates into the minor spliceosome.
What diseases are associated with U11 snRNP?
Mutations in U11 snRNP components are linked to developmental disorders, cancer, and splicing-related diseases.
What is the difference between U11 and U1 snRNP?
U11 snRNP is part of the minor spliceosome, while U1 snRNP is part of the major spliceosome; they recognize different intron types.
How can I study U11 snRNP using CRISPR?
CRISPR knockout, knock-in, and point mutation models can be used to dissect U11 snRNP gene functions.
What methods are used to analyze U11 snRNP?
RNA-seq, proteomics, cryo-EM, and CRISPR screens are common methods.
Is U11 snRNP essential for cell viability?
Yes, knockout of core U11 snRNP components is often lethal or causes severe growth defects.
What are the research tools for U11 snRNP?
Antibodies against U11-59K, tagged knock-in cell lines, and CRISPR libraries are available.
Conclusion
The U11 snRNP is a critical component of the minor spliceosome, with unique proteins and regulatory mechanisms. Its dysfunction is implicated in various diseases, making it a valuable target for CRISPR-based research. EDITGENE provides comprehensive services to support mechanistic and translational studies on U11 snRNP.
References
- 1. Benecke H et al.. 2005. The U11/U12 snRNP 65K protein acts as a molecular bridge, binding the U12 snRNA and U11-59K protein.. EMBO J 24(17):3057-69 PMID: 16096647
- 2. Will CL et al.. 2004. The human 18S U11/U12 snRNP contains a set of novel proteins not found in the U2-dependent spliceosome.. RNA 10(6):929-41 PMID: 15146077
- 3. Wassarman KM et al.. 1992. The low-abundance U11 and U12 small nuclear ribonucleoproteins (snRNPs) interact to form a two-snRNP complex.. Mol Cell Biol 12(3):1276-85 PMID: 1372090
- 4. Bai R et al.. 2024. Structural basis of U12-type intron engagement by the fully assembled human minor spliceosome.. Science 383(6688):1245-1252 PMID: 38484052
- 5. Turunen JJ et al.. 2013. HnRNPH1/H2, U1 snRNP, and U11 snRNP cooperate to regulate the stability of the U11-48K pre-mRNA.. RNA 19(3):380-9 PMID: 23335637
- 6. Niemelä EH et al.. 2015. Evolutionarily conserved exon definition interactions with U11 snRNP mediate alternative splicing regulation on U11-48K and U11/U12-65K genes.. RNA Biol 12(11):1256-64 PMID: 26479860
- 7. Bai R et al.. 2021. Structure of the activated human minor spliceosome.. Science 371(6535) PMID: 33509932
- 8. Damianov A et al.. 2004. Recycling of the U12-type spliceosome requires p110, a component of the U6atac snRNP.. Mol Cell Biol 24(4):1700-8 PMID: 14749385
